McInnes G T, Asbury M J, Shelton J R, Harrison I R, Ramsay L E, Venning G R, Clarke J M
Clin Pharmacol Ther. 1980 Mar;27(3):363-9. doi: 10.1038/clpt.1980.48.
The renal antimineralocorticoid activity of single administration of 2 sulfur-containing compounds, which are thought to be intermediate metabolites of spironolactone, was assessed in healthy subjects. They were each active in reversing the urinary electrolyte changes indiced by fludrocortisone for 2 to 10 hr after dosing, but only the 7 alpha-thiomethyl derivative exhibited activity in the period 12 to 16 hr after treatment. The activity of both drugs was less than of spironolactone. Taking urinary log 10 Na/K as the best index of antimineralocorticoid activity, the potencies of the intermediates relative to spironolactone were 0.26 (95% confidence limits, 0.12 to 0.49) for 7 alpha-thio-spirolactone and 0.33 (95% confidence limits, 0.15 to 0.62) for 7 alpha-thiomethyl-spirolactone in the period 2 to 10 hr after medication. We conclude that these minor sulfur-containing intermediate metabolites of spironolactone are unlikely to contribute significantly to the renal antimineralocorticoid activity of spironolactone.
在健康受试者中评估了单次给予2种含硫化合物(被认为是螺内酯的中间代谢产物)的肾脏抗盐皮质激素活性。给药后,它们各自在2至10小时内可有效逆转氟氢可的松引起的尿液电解质变化,但只有7α-硫甲基衍生物在治疗后12至16小时内表现出活性。两种药物的活性均低于螺内酯。以尿中log 10 Na/K作为抗盐皮质激素活性的最佳指标,用药后2至10小时内,7α-硫代螺内酯相对于螺内酯的活性为0.26(95%置信限,0.12至0.49),7α-硫甲基螺内酯为0.33(95%置信限,0.15至0.62)。我们得出结论,螺内酯这些含硫的次要中间代谢产物不太可能对螺内酯的肾脏抗盐皮质激素活性有显著贡献。